About Us

PharmoGo is a national high-tech enterprise and Shanghai specialized and sophisticated SME specializing in Model-Informed Drug Development (MIDD). 

It is dedicated to providing intelligent modeling and simulation integrated solutions for China's pharma and biotech, empowering decision-making throughout the entire drug development lifecycle.

[Core Business] The company has established a dual-driven system of "software + services": MIDD Platform: Offers solutions covering PBPK modeling, PK/PD modeling, popPK, ADMET prediction, etc.; 

End-to-end  consulting services: Provides decision-making support for innovative drug clinical translation and generic drug bioequivalence studies; International top-tier technology bridge: 

As the exclusive strategic partner of Simulations Plus in China, it integrates globally leading technical resources.

[Technical Advantages] Experienced Team: Core members possess 10+ years of industry experience, spanning multidisciplinary backgrounds in pharmacy, clinical pharmacology, etc.; 

Multi-dimensional Validation: Solutions have been validated through hundreds of innovative/generic drug projects, significantly enhancing R&D success rates.

[Industry Impact] Has served over hundreds of industry users

[Mission and Vision]PharmoGo mission is to ensure that our products and services all contribute to the advancement of the pharmaceutical industry, thereby benefiting Chinese patients.